心血管リスクバイオマーカーに対する歯周病療法の効果: 系統的レビュー

Camille Bechina, Ange Désiré Pockpa, Gilles Amador Del Valle

|August 22, 2025

まとめ

非手術による歯周病治療 (NSPT) は,心血管リスクバイオマーカーを改善し,特に炎症を軽減し,糖尿病患者または糖尿病のない患者の血糖コントロールを改善します. これらの発見は,歯周病のケアを心血管リスク管理戦略に統合することを支持しています.

科学分野:

歯周病と心臓病
組織性炎症と慢性疾患

背景:

歯周病と心血管疾患は同じ炎症経路を持っています
口腔からの細菌の転移は全身の炎症に寄与する.

研究の目的:

心血管リスクバイオマーカーに対する非手術性歯周治療 (NSPT) の影響を体系的に検討する.
内皮機能,全身炎症,血栓形成,脂質/グルコース代謝への影響を評価する.

主な方法:

PubMed,Cochrane Library,Scopusのデータベースを体系的に検索する (2010年以降)
NSPTで治療された中等から重度の歯周炎の成人の患者も含まれていました.
バイアスのリスク評価は全ての研究で実施された.

主要な成果:

NSPTは高感度C反応性タンパク質 (hs-CRP) と炎症性サイトカイン (IL-6,TNF-α) を有意に減少させた.
特に2型糖尿病患者では,HbA1c値が低下しました.
内皮機能が改善され,内皮微粒子が減少した. 血管のパラメータ結果は異質であった.

結論:

NSPTは炎症と血糖コントロールを改善することで臨床的関連性を示しています.
歯周病の管理に歯周病のケアを組み込むことを支持しています
脂質代謝と血管機能への影響については,さらなる研究が必要である.

キーワード:

動脈硬化症心血管リスク歯周病外周動脈疾患治療法

さらに関連する動画

06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.1K

07:15

Robust Ligature-Induced Model of Murine Periodontitis for the Evaluation of Oral Neutrophils

Published on: January 21, 2020

11.6K

関連する概念動画

01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

213

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

213

01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

334

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

334

01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

01:23

Assessment of the Cardiovascular System I: Subjective Data

467

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

467

関連する実験動画